Acquired APC resistance and oral contraceptives : differences between two functional testsCURVERS, J; THOMASSEN, M. C. L. G. D; NICOLAES, G. A. F et al.British journal of haematology. 1999, Vol 105, Num 1, pp 88-94, issn 0007-1048Article

Activation of human factor V by meizothrombinTANS, G; NICOLAES, G. A. F; THOMASSEN, M. C. L. G. D et al.The Journal of biological chemistry (Print). 1994, Vol 269, Num 23, pp 15969-15972, issn 0021-9258Article

The effect of phospholipids, calcium ions and protein S on rate constants of human factor Va inactivation by activated human protein CBAKKER, H. M; TANS, G; JANSSE-CLAESSEN, T et al.European journal of biochemistry (Print). 1992, Vol 208, Num 1, pp 171-178, issn 0014-2956Article

Effect of in vitro fertilization treatment and subsequent pregnancy on the protein C pathwayCURVERS, J; NAP, A. W; THOMASSEN, M. C. L. G. D et al.British journal of haematology. 2001, Vol 115, Num 2, pp 400-407, issn 0007-1048Article

Low-dose oral contraceptives and acquired resistance to activated protein C : a randomised cross-over studyROSING, J; MIDDELDORP, S; CURVERS, J et al.Lancet (British edition). 1999, Vol 354, Num 9195, pp 2036-2040, issn 0140-6736Article

Oral contraceptives and venous thrombosis : different sensitivities to activated protein C in women using second- and third-generation oral contraceptivesROSING, J; TANS, G; NICOLAES, G. A. F et al.British journal of haematology. 1997, Vol 97, Num 1, pp 233-238, issn 0007-1048Article

A randomized cross-over study on the effects of levonorgestrel- and desogestrel-containing oral contraceptives on the anticoagulant pathwaysTANS, G; CURVERS, J; MIDDELDORP, S et al.Thrombosis and haemostasis. 2000, Vol 84, Num 1, pp 15-21, issn 0340-6245Article

Effect of activated protein C on thrombin generation and on the thrombin potential in plasma of normal and APC-resistant individualsNICOLAES, G. A. F; THOMASSEN, M. C. L. G. D; TANS, G et al.Blood coagulation & fibrinolysis. 1997, Vol 8, Num 1, pp 28-38, issn 0957-5235Article

Characterization of two forms of human factor Va with different cofactor activitiesROSING, J; BAKKER, H. M; BAKKER, H. M et al.BAKKER, H. M; BAKKER, H. M et al.The Journal of biological chemistry (Print). 1993, Vol 268, Num 28, pp 21130-21136, issn 0021-9258Article

Venous thrombosis and changes of hemostatic variables during cross-sex hormone treatment in transsexual peopleTOORIANS, A. W. F. T; THOMASSEN, M. C. L. G. D; ZWEEGMAN, S et al.The Journal of clinical endocrinology and metabolism. 2003, Vol 88, Num 12, pp 5723-5729, issn 0021-972X, 7 p.Article

A prothrombinasse-based assay for detection of resistance to activated protein CNICOLAES, G. A. F; THOMASSEN, M. C. L. G. D; VAN OERLE, R et al.Thrombosis and haemostasis. 1996, Vol 76, Num 3, pp 404-410, issn 0340-6245Article

Functional properties of human factor Va lacking the Asp⁶⁸³-Arg⁷⁰⁹ domain of the heavy chainBAKKER, H. M; TANS, G; THOMASSEN, M. C. L. G. D et al.The Journal of biological chemistry (Print). 1994, Vol 269, Num 32, pp 20662-20667, issn 0021-9258Article

Progoagulant activities in venoms from central asian snakesYUKELSON, L. Y; TANS, G; THOMASSEN, M. C. L. G. D et al.Toxicon (Oxford). 1991, Vol 29, Num 4-5, pp 491-502, issn 0041-0101, 12 p.Article